Download FREE Report Sample
Download Free sampleSARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
SARS-Cov-2 Vaccine Market contains market size and forecasts of SARS-Cov-2 Vaccine (Vero Cell) in global, including the following market information:
Global SARS-Cov-2 Vaccine (Vero Cell) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global SARS-Cov-2 Vaccine (Vero Cell) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five SARS-Cov-2 Vaccine (Vero Cell) companies in 2021 (%)
The global SARS-Cov-2 Vaccine (Vero Cell) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Whole Virus Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of SARS-Cov-2 Vaccine (Vero Cell) include Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China and WIBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the SARS-Cov-2 Vaccine (Vero Cell) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global SARS-Cov-2 Vaccine (Vero Cell) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SARS-Cov-2 Vaccine (Vero Cell) Market Segment Percentages, by Type, 2021 (%)
Whole Virus Inactivated Vaccine
Split Vaccine
Subunit Vaccine
Others
Global SARS-Cov-2 Vaccine (Vero Cell) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SARS-Cov-2 Vaccine (Vero Cell) Market Segment Percentages, by Application, 2021 (%)
Special Population
General Population
Global SARS-Cov-2 Vaccine (Vero Cell) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SARS-Cov-2 Vaccine (Vero Cell) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies SARS-Cov-2 Vaccine (Vero Cell) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies SARS-Cov-2 Vaccine (Vero Cell) revenues share in global market, 2021 (%)
Key companies SARS-Cov-2 Vaccine (Vero Cell) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies SARS-Cov-2 Vaccine (Vero Cell) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sinopharm
Sinovac Biotech
BIBP
IMBCAMS,China
WIBP
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
